Therapeutically blocking interleukin-11 receptor-α enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours

Amy Winship(Discovery Institute), Evdokia Dimitriadis(Royal Women's Hospital)
Oncotarget
February 8, 2017
Cited by 26


Related Papers